Gapping up
In reaction to disappointing earnings/guidance:
- CVGI +14.4%, SMCI +11.4%, P +11%, TWI +9.6%, MDRX +8.9%, VIAV +8.6%, SHAK +8.6%, CATM +8.3%, CRC +8.2%, ACAD +7.5%, WTW +7.3%, WIFI +7.2%, MED +6.7%, CTRL +6.5%, ESNT +5.7%, PE +5.5%, BGS +5.5%, MTLS +5%, LYV +4.4%, SPPI +4.3%, STMP +4.2%, AKAO +4%, WING +3.6%, EC +3.6%, HMSY +3.6%, CYRX +3.5%, CC +3.5%, CARG +3.3%, IDXX +2.9%, AGO +2.8%, CBS +2.7%, CYBR +2.6%, SM +2.5%, ADMS +2.5%, CBOE +2.5%, IONS +2.5%, APPN +2.4%, AON +2.3%, CELG +2.3%, VIRT +2.2%, MSI +2.1%, NWL +1.8%, MAIN +1.7%, TXMD +1.6%, BABA +1.6%, STWD +1.5%, OLED +1.4%, ACIA +1.4%, BPY +1.4%, ALNY +1.3%, ITGR +1.1%
M&A news:
- AAXN +1.4% (acquires VIEVU)
Other news:
- PTLA +28.1% (receives FDA approval for Andexxa)
- AAPL +1.1% (CNBC reported Warren Buffet increased his Apple investment by 45% in Q1 to ~240 million shares, currently ~$43 billion)
- MDR +0.9% (to join S&P MidCap 400)
Analyst comments:
- FMC +1.2% (upgraded to Overweight from Equal-Weight at Stephens)